Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Metastatic × Carboplatin × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 42 Urinary Bladder Neoplasms 37 Carcinoma, Transitional Cell 27 Testicular Neoplasms 25 Ovarian Neoplasms 25 Testicular Germ Cell Tumor 13 Carcinoma, Non-Small-Cell Lung 13 Pancreatic Neoplasms 11 Urethral Neoplasms 10 Teratoma 10 Kidney Neoplasms 10 Carcinoma, Renal Cell 10 Breast Neoplasms 10 Wilms Tumor 9 Sarcoma 9 Melanoma 9 Colorectal Neoplasms 9 Central Nervous System Neoplasms 9 Stomach Neoplasms 7 Ovarian Germ Cell Cancer 7 Neoplasms 7 Seminoma 6 Neuroectodermal Tumors, Primitive, Peripheral 6 Neoplasm Metastasis 6 Ureteral Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Osteosarcoma 5 Medulloblastoma 5 Endodermal Sinus Tumor 5 Carcinoma, Embryonal 5

Interventions

enzalutamide 7 Prednisone 7 cabazitaxel 6 Radiosurgery 6 Docetaxel 5 Androgen Antagonists 4 Abiraterone Acetate 4 XRP6258 2 talazoparib 1 sipuleucel-T 1 rucaparib 1 pembrolizumab 1 olaparib 1 gallium 68 PSMA-11 1 fludrocortisone acetate 1 darolutamide 1 apalutamide 1 Zuclomiphene 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisolone 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 LY3023414 1 Injections 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05563558 2024-06-11

PEAPOD_FOS

Fundacion Oncosur

Phase 2 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡